Lata Medical Research Foundation, Nagpur, India Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2004
NCT00513396
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Lata Medical Research Foundation | Lata Medical Research Foundation, Nagpur

Active Ingredients

Drugs in Phase 3 Trials (3)

azithromycin (zithromax) (1 trial)

iron (1 trial)

isoniazid (nydrazid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Death (Phase 3)

Infections (Phase 3)

Maternal Death (Phase 3)

Neonatal Sepsis (Phase 3)

Perinatal Death (Phase 3)

Pregnancy Complications, Infectious (Phase 3)

Puerperal Infection (Phase 3)

Sepsis (Phase 3)

Toxemia (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3